Editas Medicine (EDIT) Stock Price, Quote & News

Company Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. Its lead program is EDIT-401, a one-time therapy designed to reduce LDL cholesterol through the upregulation of the LDL receptor to treat hyperlipidemia. The company also develops therapies to treat Sickle cell disease and transfusion-dependent beta thalasse...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 401 9000

Website: www.editasmedicine.com

Address:

11 Hurley Street, Cambridge, United States

Scalptrades101 Aug. 21 at 1:38 PM

$SPY $QQQ $EDIT Another scary dip paid! Dont sleep on $KLAR or $LUNR

0 · Reply

Whoami1989 Aug. 20 at 8:20 PM

$EDIT there a lot of pump and dump idiots on this board. beware !!!

0 · Reply

Scalptrades101 Aug. 20 at 7:49 PM

$SPY $QQQ lots of good stocks getting beaten down today, picking up $EDIT on sale next 💎

0 · Reply

MoneyMacG Aug. 20 at 7:39 PM

$CAVA $EDIT $DGXX $INVZ $CAI w..

0 · Reply

ppstream Aug. 20 at 6:29 PM

$EDIT they play with you guys all the time…

0 · Reply

Whoami1989 Aug. 20 at 5:57 PM

$EDIT how pathetic fake pump and dump is it

0 · Reply

Robert_Dempster Aug. 20 at 1:59 PM

$EDIT looks like were unwinding yesterday's treasury intervention temporary blip🐂

0 · Reply

AdmiralTweezers Aug. 20 at 12:05 PM

$BEAM $CRSP $EDIT $NTLA Falling Treasury yields → lower discount rates → higher present value of future profits → higher theoretical valuations for biotech/growth stocks

0 · Reply

AdmiralTweezers Aug. 20 at 10:28 AM

$BEAM $CRSP $EDIT $NTLA actually the same thing sliming bitcoin is making biotech spike…. Lower treasury yields are bringing $$$ back into biotech especially companies in niche areas like CRISPR. All of ththis se will go back up through sept and November….

1 · Reply